Literature DB >> 15342925

The relationship between disease activity and quality of life in systemic lupus erythematosus.

S Khanna1, H Pal, R M Pandey, R Handa.   

Abstract

OBJECTIVE: To determine the quality of life (QOL) in SLE patients and correlate it with disease activity.
METHODS: Lupus patients fulfilling the ACR 1997 criteria for SLE were included in this cross-sectional study. Patients were administered the World Health Organization Quality of Life-Bref (WHOQOL-Bref) to assess their quality of life. Disease activity was measured using Mexican Systemic Lupus Erythematosus Disease Activity Index (Mex-SLEDAI).
RESULTS: The study group comprised 73 lupus patients (70 females and three males) with mean age 35.22 +/- 11.15 yr and mean disease duration 5.62 +/- 5.14 yr. Mean Mex-SLEDAI score was 3.31 +/- 3.19. Higher disease activity scores were associated with lower QOL scores in the physical (P = 0.001) and psychological domains (P = 0.01) but showed no significant correlation with the domains of social and environmental QOL. Patients with clearly active and probably active disease showed significantly lower scores in the physical (P = 0.01) and psychological (P = 0.02) domains than patients with inactive disease. However, no significant difference was found in the domains of social and environmental QOL. Age or disease duration did not affect the QOL in any of the domains.
CONCLUSIONS: Physical and psychological QOL are impaired to a larger extent in active lupus. However, social and environmental QOL do not correlate with the disease activity status in lupus patients.

Entities:  

Mesh:

Year:  2004        PMID: 15342925     DOI: 10.1093/rheumatology/keh376

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  22 in total

Review 1.  Rheumatology in India--quo vadis?

Authors:  Rohini Handa
Journal:  Nat Rev Rheumatol       Date:  2014-11-04       Impact factor: 20.543

2.  Systemic lupus erythematosus in a multiethnic US cohort LUMINA (XLI): factors predictive of self-reported work disability.

Authors:  A M Bertoli; M Fernández; G S Alarcón; L M Vilá; J D Reveille
Journal:  Ann Rheum Dis       Date:  2006-06-30       Impact factor: 19.103

3.  BMI, disease activity, and health-related quality-of-life in systemic lupus erythematosus.

Authors:  Li-Wei Zhu; Tao Zhang; Hai-Feng Pan; Xiang-Pei Li; Dong-Qing Ye
Journal:  Clin Rheumatol       Date:  2010-05-02       Impact factor: 2.980

Review 4.  The clinical significance of antiphospholipid antibodies in systemic lupus erythematosus.

Authors:  Ozan Ünlü; Stephane Zuily; Doruk Erkan
Journal:  Eur J Rheumatol       Date:  2015-12-29

Review 5.  Quality-of-life measurements versus disease activity in systemic lupus erythematosus.

Authors:  Adnan N Kiani; Michelle Petri
Journal:  Curr Rheumatol Rep       Date:  2010-08       Impact factor: 4.592

6.  Health-related quality of life and employment among persons with systemic lupus erythematosus.

Authors:  Jinoos Yazdany; Edward Yelin
Journal:  Rheum Dis Clin North Am       Date:  2010-02       Impact factor: 2.670

Review 7.  Quality-of-life measurements in multiethnic patients with systemic lupus erythematosus: cross-cultural issues.

Authors:  Sergio M A Toloza; Meenakshi Jolly; Graciela S Alarcón
Journal:  Curr Rheumatol Rep       Date:  2010-08       Impact factor: 4.592

8.  Disability in valued life activities among individuals with systemic lupus erythematosus.

Authors:  Patricia Katz; Anne Morris; Laura Trupin; Jinoos Yazdany; Edward Yelin
Journal:  Arthritis Rheum       Date:  2008-04-15

9.  Functional disability and health-related quality of life in South Africans with rheumatoid arthritis and systemic lupus erythematosus.

Authors:  Romela Benitha; Mohammed Tikly
Journal:  Clin Rheumatol       Date:  2006-03-15       Impact factor: 2.980

10.  The Chinese version of the SLEQOL is a reliable assessment of health-related quality of life in Han Chinese patients with systemic lupus erythematosus.

Authors:  Hai-Zhi Jiang; Zhi-Guo Lin; Hong-Juan Li; Qing -Du; Wei -Tian; Shu-Ya Wang; Shang-Qi Guan; Yi-Fang Mei
Journal:  Clin Rheumatol       Date:  2017-11-22       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.